Group 1: Haier Biomedical - Haier Biomedical showcased multiple technological products and digital solutions aimed at addressing practical needs in research and laboratory settings, including a super-speed centrifuge that achieves speeds of 100,000 RPM, filling a domestic gap in the field [2] - The company introduced a fully enclosed automated cell expansion system that enhances consistency and reproducibility in experiments by automating the cell culture process and ensuring data traceability [2] - Haier's biological sample management solution utilizes NAIT recognition technology for automated management in ultra-low temperature environments, significantly reducing labor costs and improving data accuracy [2] - The company presented energy-efficient products, such as ultra-low temperature storage boxes, which reportedly consume 50% less electricity than traditional models [2][3] - Haier Biomedical's products and solutions are now available in over 160 countries and regions, with a commitment to advancing technology development based on user challenges in real-world applications [3] Group 2: Medtronic - Medtronic announced the full localization of its product line in China, showcasing its "fully localized innovative solutions" at the expo, which includes core products for tumor treatment [5] - The company highlighted its Leksell Gamma Knife Elekta Esprit, which supports millimeter-level precision in radiation therapy, and the Elekta Evo platform that integrates AI imaging technology to enhance operational efficiency [5][6] - Medtronic's Elekta Unity system has treated over 10,000 patients since its introduction in China, covering more than 40 types of tumors and generating over 160 related clinical research papers [5][7] - The company aims to support China's "Healthy China 2030" initiative by promoting high-quality radiation therapy technology [7] Group 3: Fosun Pharma - Fosun Pharma presented various innovative drugs and high-end medical devices at the expo, focusing on improving treatment outcomes and quality of life for patients with diseases such as tumors and neurological disorders [8] - The company introduced the Da Vinci surgical robot and CAR-T cell therapy product Yikaida, which has been included in over 110 health insurance plans, enhancing accessibility for lymphoma patients [9] - Fosun's Marie particle therapy system, approved by the FDA, offers a compact design for rapid deployment in hospitals, improving treatment precision for lung and breast tumors [8][9] - The company is actively promoting the application of artificial intelligence in healthcare, with platforms designed for drug decision-making and clinical trial predictions [10]

Core Insights - The China International Import Expo (CIIE) serves as a significant platform for showcasing innovation and collaboration, with Haier Biomedical presenting multiple cutting-edge technologies and solutions this year [1][3] Group 1: Breakthrough Technologies and Innovations - Haier Biomedical introduced the first domestic ultra-speed centrifuge capable of exceeding 100,000 RPM, filling a gap in high-end centrifuge equipment in China and positioning the country as the third globally to master this technology [3] - The company also launched a fully automated closed cell expansion system, designed for cell culture and exosome preparation, which enhances efficiency and reduces contamination risks [3] - The AI-driven low-temperature storage management solution, based on original -86°C NAIT recognition technology, streamlines sample management processes, significantly improving operational efficiency for researchers [5] Group 2: Green Development and Sustainability - Haier Biomedical emphasizes green development, showcasing energy-efficient products that save 50% in daily electricity consumption compared to traditional models, equating to an annual saving of 2,843 kWh [6] - The company has established a comprehensive green value chain covering procurement, manufacturing, logistics, and product lifecycle, with 44 product models receiving Energy Star certification [6] - Haier Biomedical's solar-powered vaccine refrigerators and mobile laboratories have been deployed in over 80 countries along the Belt and Road Initiative, contributing to the "Green Silk Road" [6] Group 3: Global Market Expansion - The company has adopted a localized strategy, with products and solutions reaching over 160 countries and benefiting more than 100 million users globally [7][8] - Haier Biomedical's participation in the CIIE highlights its commitment to high-level openness and innovation in the life sciences sector, with a focus on ecological integration and resource efficiency [8]